PhoenixBio Co., Ltd. (JP:6190)
:6190
Want to see JP:6190 full AI Analyst Report?
Total Valuation
PhoenixBio Co., Ltd. has a market cap or net worth of ¥1.53B. The enterprise value is ¥1.06B.
Market Cap¥1.53B
Enterprise Value¥1.06B
Share Statistics
PhoenixBio Co., Ltd. has 4,076,933 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,076,933
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PhoenixBio Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 3.87%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)3.87%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee22.36M
Profits Per Employee1.79M
Employee Count70
Asset Turnover0.71
Inventory Turnover1.22
Valuation Ratios
The current PE Ratio of PhoenixBio Co., Ltd. is 12.2. PhoenixBio Co., Ltd.’s PEG ratio is -0.11.
PE Ratio12.2
PS Ratio1.14
PB Ratio1.15
Price to Fair Value1.15
Price to FCF31.70
Price to Operating Cash Flow0.00
PEG Ratio-0.11
Income Statement
In the last 12 months, PhoenixBio Co., Ltd. had revenue of 1.57B and earned 125.23M in profits. Earnings per share was 30.81.
Revenue1.57B
Gross Profit1.19B
Operating Income82.77M
Pretax Income131.44M
Net Income125.23M
EBITDA116.52M
Earnings Per Share (EPS)30.81
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
PhoenixBio Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-1.06%
50-Day Moving Average433.94
200-Day Moving Average460.91
Relative Strength Index (RSI)32.11
Average Volume (3m)360.67K
Important Dates
PhoenixBio Co., Ltd. upcoming earnings date is Aug 19, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
PhoenixBio Co., Ltd. as a current ratio of 4.40, with Debt / Equity ratio of 31.34%
Current Ratio4.40
Quick Ratio3.58
Debt to Market Cap0.20
Net Debt to EBITDA-5.67
Interest Coverage Ratio17.25
Taxes
In the past 12 months, PhoenixBio Co., Ltd. has paid 6.21M in taxes.
Income Tax6.21M
Effective Tax Rate0.05
Enterprise Valuation
PhoenixBio Co., Ltd. EV to EBITDA ratio is 9.68, with an EV/FCF ratio of 19.99.
EV to Sales0.72
EV to EBITDA9.68
EV to Free Cash Flow19.99
EV to Operating Cash Flow16.38
Balance Sheet
PhoenixBio Co., Ltd. has ¥1.04B in cash and marketable securities with ¥503.59M in debt, giving a net cash position of ¥532.32M billion.
Cash & Marketable Securities¥1.04B
Total Debt¥503.59M
Net Cash¥532.32M
Net Cash Per Share¥130.57
Tangible Book Value Per Share¥381.97
Margins
Gross margin is 76.69%, with operating margin of 5.29%, and net profit margin of 8.00%.
Gross Margin76.69%
Operating Margin5.29%
Pretax Margin8.40%
Net Profit Margin8.00%
EBITDA Margin7.44%
EBIT Margin5.29%
Analyst Forecast
The average price target for PhoenixBio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.57%
EPS Growth Forecast―